Search -

Displaying 181 - 195 of 195

Sort: Relevancy | Date

Presentation TCT 2012

Inpatient and Outpatient Management After Alcohol Septal Ablation

Presenter: Michael Fifer

October 25, 2012

Presentation TCT 2012

Historical Perspective on Alcohol Septal Ablation

Presenter: Ulrich Sigwart

October 25, 2012

Presentation TCT 2012

HCM Management: What Do the Guidelines Say?

Presenter: Bernard Gersh

October 25, 2012

Presentation TCT 2012

HCM and Sudden Cardiac Death: When to Consider an ICD

Presenter: Bernard Gersh

October 25, 2012

Presentation TCT 2012

Great Case 3

Presenter: Rod Stables

October 25, 2012

Presentation TCT 2012

Great Case 2

Presenter: Carey Kimmelstiel

October 25, 2012

Presentation TCT 2012

Great Case 1

Presenter: Valerian Fernandes

October 25, 2012

Presentation TCT 2012

Epidemiology and Natural History of HCM

Presenter: John Douglas Jr

October 25, 2012

Presentation TCT 2012

Complications: How to Avoid, How to Treat

Presenter: Srihari Naidu

October 25, 2012

Presentation TCT 2012

Case Selection for Alcohol Septal Ablation

Presenter: Sherif Nagueh

October 25, 2012

Presentation TCT 2012

Tough Call During a HOCM Ablation

Presenter: Carey Kimmelstiel

October 24, 2012

Presentation

Survival After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy

Presenter: Paul Sorajja

October 19, 2012

Presentation ACVS 2012

Interventional Treatment of HOCM: Overview of Techniques and Results

Presenter: Rajeev Lochan

August 03, 2012

Presentation Fellows 2012

Hypertrophic Cardiomyopathy and Alcohol Septal Ablation

Presenter: Srihari Naidu

April 22, 2012

Presentation TCT 2012

The Mitochondrial Permeability Transition Pore is a Target for Pharmacological Cardioprotection in Human Hypertrophic Cardiomyopathy

Presenter: Paul S. Rees, Sean M. Davidson, Sian E. Harding, Perry M. Elliott, Derek J. Hausenloy, Derek M. Yellon

January 03, 2012

Advertisement

Inpatient and Outpatient Management After Alcohol Septal Ablation

Historical Perspective on Alcohol Septal Ablation

HCM Management: What Do the Guidelines Say?

HCM and Sudden Cardiac Death: When to Consider an ICD

Great Case 3

Great Case 2

Great Case 1

Epidemiology and Natural History of HCM

Complications: How to Avoid, How to Treat

Case Selection for Alcohol Septal Ablation

Tough Call During a HOCM Ablation

Survival After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy

Interventional Treatment of HOCM: Overview of Techniques and Results

Hypertrophic Cardiomyopathy and Alcohol Septal Ablation

The Mitochondrial Permeability Transition Pore is a Target for Pharmacological Cardioprotection in Human Hypertrophic Cardiomyopathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content